MK0966

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0966, covering 2017-05-09 to 2017-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201) [Phase 3]